We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+21.79%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.16B
AUM Growth
+$372M
Cap. Flow
+$132M
Cap. Flow %
11.39%
Top 10 Hldgs %
68.38%
Holding
232
New
129
Increased
24
Reduced
12
Closed
56

Top Buys

Rank Stock Value
1
SANA icon
Sana Biotechnology
SANA
+$72.8M
2
PBR.A icon
Petrobras Class A
PBR.A
+$20.9M
3
AMP icon
Ameriprise Financial
AMP
+$11.4M
4
MET icon
MetLife
MET
+$10.1M
5
WFC icon
Wells Fargo
WFC
+$7.59M

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$114M
2
MU icon
Micron Technology
MU
+$7.77M
3
UDR icon
UDR
UDR
+$5.92M
4
EQH icon
Equitable Holdings
EQH
+$4.95M
5
LRCX icon
Lam Research
LRCX
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 61.94%
2 Financials 15.05%
3 Materials 5.33%
4 Technology 3.84%
5 Energy 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWSA icon
201
News Corp Class A
NWSA
$14.9B
– –
-19,000
Closed -$483K
ORCL icon
202
Oracle
ORCL
$374B
– –
-12,900
Closed -$905K
PARA
203
CALL
DELISTED
Paramount Global Class B
PARA
– –
-6,000
Closed -$271K
PKX icon
204
POSCO
PKX
$16.1B
– –
-12,000
Closed -$866K
QQQ icon
205
PUT
Invesco QQQ Trust
QQQ
$453B
– –
-7,000
Closed -$2.23M
RGA icon
206
Reinsurance Group of America
RGA
$15.5B
– –
-21,781
Closed -$2.75M
SPY icon
207
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-5,000
Closed -$1.98M
SYNA icon
208
Synaptics
SYNA
$4.19B
– –
-8,300
Closed -$1.12M
T icon
209
AT&T
T
$159B
– –
-39,720
Closed -$908K
TMUS icon
210
T-Mobile US
TMUS
$185B
– –
-5,000
Closed -$626K
TMUS icon
211
PUT
T-Mobile US
TMUS
$185B
– –
-3,000
Closed -$376K
TSLA icon
212
Tesla
TSLA
$1.23T
– –
-1,050
Closed -$234K
UBER icon
213
Uber
UBER
$143B
– –
-4,500
Closed -$245K
UDR icon
214
UDR
UDR
$12.3B
– –
-135,000
Closed -$5.92M
V icon
215
Visa
V
$684B
– –
-10,000
Closed -$2.12M
V icon
216
PUT
Visa
V
$684B
– –
-1,700
Closed -$360K
WBD icon
217
CALL
Warner Bros
WBD
$65.9B
– –
-10,000
Closed -$435K
ACH
218
DELISTED
Alum Corp of China Ltd
ACH
– –
-28,811
Closed -$301K
BOWX
219
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
– –
-125,000
Closed -$1.46M
BBL
220
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
– –
-25,000
Closed -$1.45M
UFS
221
DELISTED
DOMTAR CORPORATION (New)
UFS
– –
-100,506
Closed -$3.71M
5 6 7 8
9

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q2 2021 Portfolio in Review

As of Q2 2021, Crestline Management held 232 positions worth $1.16B, up 47% from $788M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Crestline Management deployed $132M of net new capital in Q2 2021, opening 129 new positions and adding to 24 existing holdings. Its largest new stake was Sana Biotechnology: 3,210,937 shares worth $63.1M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 72% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Denali Therapeutics, an estimated $114M trimmed.

  • Crestline Management's largest Q2 2021 buy was Sana Biotechnology: 3,210,937 shares worth $63.1M.
  • Crestline Management added most to Travelers Companies in Q2 2021, an estimated $6.82M increase.
  • Crestline Management's biggest Q2 2021 reduction was Denali Therapeutics, cutting an estimated $114M.
  • Crestline Management fully exited Micron Technology in Q2 2021, selling an estimated $7.77M.
  • Crestline Management's ten largest holdings make up 68% of its $1.16B portfolio in Q2 2021.
  • Crestline Management opened 129 new positions and closed 56 in Q2 2021.
  • Crestline Management's portfolio value rose 47% quarter-over-quarter to $1.16B.

Based on Crestline Management's 13F filing for Q2 2021, filed 13 Aug 2021.